Tag archive for ‘Diabetes’
AstraZeneca’s Indian subsidiary scraps Dapagliflozin distribution deal with Abbott Healthcare
By businessnewstoday On Sunday, May 30th, 2021

AstraZeneca India scraps Dapagliflozin distribution deal with Abbott

AstraZeneca Pharma India (AstraZeneca India) said that it has scrapped its distribution agreement with Abbott Healthcare pertaining to its Type 2 diabetes drug Dapagliflozin in India. As per an agreement signed More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Saturday, July 11th, 2020

CenterLab’s anti-diabetic drug candidate CS02 meets primary endpoint in phase 2 trial

Taiwanese pharma company Center Laboratories (CenterLab) said that its anti-diabetic drug candidate CS02 has met the primary endpoint of a phase 2 clinical trial. According to Center Laboratories, the orally administered More...

By pharmanewsdaily On Sunday, June 14th, 2020

Medtronic secures $337m from Blackstone to develop diabetes technologies

Irish medical device company Medtronic has secured a $337 million product investment from Blackstone Life Sciences for advancing new, innovative products particularly designed to ease the burden of diabetes management. Through More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, June 12th, 2020

Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes

Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations to regulate high blood sugar in adults with More...

By pharmanewsdaily On Saturday, January 4th, 2020

ForaCare Suisse launches FOR A 6 GTel diabetes monitoring device

ForaCare Suisse has launched a new cellular multi-functional diabetes monitoring device FORA 6 GTel based on its Lab in the Pocket technology. The Lab in the Pocket technology, which has also been newly launched, More...

Novo Nordisk acquisition of Ziylo
By Soujanya Ravi On Friday, August 24th, 2018

Novo Nordisk acquires glucose binding molecules developer Ziylo

Novo Nordisk acquisition of Ziylo : Danish pharma company Novo Nordisk  has acquired Ziylo, a University of Bristol spin-out biotechnology company, in a deal that could cross $800 million to support its goal to More...

By pharmanewsdaily On Sunday, May 6th, 2018

Pterocarpus marsupium benefits for diabetes | Pterocarpus marsupium uses

Pterocarpus marsupium works well for treating diabetes. Know about pterocarpus marsupium uses, chemical constituents and synonyms in this post. Source and Distribution of Pterocarpus: Pterocarpus consists of the More...

By pharmanewsdaily On Friday, May 4th, 2018

Green Coffee health benefits | Green Coffee helps in weight loss

For all those coffee lovers who cannot start your day without a cup of coffee, here is a new coffee drink termed as green coffee with many health benefits. Enjoy your cup of green coffee and keep all your worries More...

By pharmanewsdaily On Thursday, May 3rd, 2018

Extract from Broccoli may become secret cure for diabetes

In a report from Daily Mail, it is reported that a compound present in Broccoli extract can become a secret cure for diabetes for controlling blood sugar levels in diabetic patients. If diabetic patients consume More...

Baltim South West gas field
By pharmanewsdaily On Wednesday, March 14th, 2018
1 Comment

What is Diabetes Mellitus Disease? | Diabetes Symptoms and Treatment

In this Lifestyle Disease Article, we will give you Diabetes introduction and all the information you need on diabetes symptoms, causes and treatment along with diabetes prevention and control. We will also talk More...